Ari Meisel on Curing the Incurable Through Self-Experimentation

October 10, 2011

Ari cured himself of Crohn’s disease by experimenting with some unusual supplements, nutrition and fitness regimens, and tracking every bit of it.

Four years ago, Ari was diagnosed with Crohn’s disease. After a couple of years of intense pain, sixteen pills a day, and yet another visit to the hospital, he decided to take control of his pain. So he started to track everything. His tracking regimen included exercise, supplements, sleep, food, etc. He used some popular tracking tools such as the FitBit, Zeo, and 23andMe. He correlated these metrics with how much pain he was in and his mood. The difficult part was trying to quantify the psychological component.

Ari learned to control the pain from Crohn’s. It took a certain combination of food, supplements, exercise and sleep, but the key was collecting enough data through experimentation. The other key learning from Ari’s work was that sharing the data is very important. Sharing included his friends, family, doctor, and others with Crohn’s. This sharing of data helped him analyze the data better and made him feel better about the task. (Filmed at the NY Quantified Self Show&Tell #13 at NYU ITP.)

Related Posts

CGM Show&Tell June 13 2023

Gary Wolf

June 13, 2023

Ari cured himself of Crohn’s disease by experimenting with some unusual supplements, nutrition and fitness regimens, and tracking every bit of it. Four years ago, Ari was diagnosed with Crohn’s disease. After a couple of years of intense pain, sixteen pills a day, and yet another visit to the hospital, he decided to take control...

New Show&Tell Event: Tracking Blood Glucose

Gary Wolf

May 31, 2023

Please join us for an hour of short "QS Show&Tell" talks about diet and metabolic discoveries using personal science. This session will focus on minimally invasive blood glucose monitor and meal and activity tracking with Nutrisense.

Astronauts

Gary Wolf

February 23, 2023

We The Scientists, a new book by Amy Dockser Marcus, tells the story of a group of families who force research attention on a rare disease